Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Blais

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Heart Failure Reviews|October 16, 2002
Nitric oxide, cell death, and heart failureJun-ichi Oyama, Stefan Frantz, Charles Blais, et al.
Canadian Journal of Physiology and Pharmacology|March 26, 2002
Effects of captopril and omapatrilat on early post-myocardial infarction survival and cardiac hemodynamics in rats: interaction with cardiac cytokine expressionCharles Blais, Nathalie Lapointe, Jean-Lucien Rouleau, et al.
Circulation|February 19, 2004
Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient miceJun-ichi Oyama, Charles Blais, Xiaoli Liu, et al.
Journal of the American College of Cardiology|May 22, 2002
Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the ratNathalie Lapointe, Charles Blais, Albert Adam, et al.
Molecular and Cellular Biochemistry|December 17, 2003
Comparative effects of a vasopeptidase inhibitor vs. an angiotensin converting enzyme inhibitor on cardiomyocyte apoptosis in rats with heart failureNathalie Lapointe, James N Tsoporis, Thomas G Parker, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2008
Discovery of 4-aryl-2-oxo-2H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assayWilliam Kemnitzer, Songchun Jiang, Hong Zhang, et al.
Journal of Medicinal Chemistry|November 30, 2004
Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl groupWilliam Kemnitzer, John Drewe, Songchun Jiang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Heart Failure Reviews|October 16, 2002
Nitric oxide, cell death, and heart failureJun-ichi Oyama, Stefan Frantz, Charles Blais, et al.
Canadian Journal of Physiology and Pharmacology|March 26, 2002
Effects of captopril and omapatrilat on early post-myocardial infarction survival and cardiac hemodynamics in rats: interaction with cardiac cytokine expressionCharles Blais, Nathalie Lapointe, Jean-Lucien Rouleau, et al.
Circulation|February 19, 2004
Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient miceJun-ichi Oyama, Charles Blais, Xiaoli Liu, et al.
Journal of the American College of Cardiology|May 22, 2002
Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the ratNathalie Lapointe, Charles Blais, Albert Adam, et al.
Molecular and Cellular Biochemistry|December 17, 2003
Comparative effects of a vasopeptidase inhibitor vs. an angiotensin converting enzyme inhibitor on cardiomyocyte apoptosis in rats with heart failureNathalie Lapointe, James N Tsoporis, Thomas G Parker, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2008
Discovery of 4-aryl-2-oxo-2H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assayWilliam Kemnitzer, Songchun Jiang, Hong Zhang, et al.
Journal of Medicinal Chemistry|November 30, 2004
Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl groupWilliam Kemnitzer, John Drewe, Songchun Jiang, et al.
Pageof 1